Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Extel 2010

16 Jun 2010 09:19

RNS Number : 6983N
Arden Partners plc
16 June 2010
 



Arden Partners plc

("Arden" or the "Company")

Arden Partners, the institutional stockbroker, is delighted that its equity brokerage and research teams ranked highly in Extel's 2010 UK Survey. 

Fund managers voted Arden No. 1 for broking Financials (Jeremy Grime, Sarah Spikes, Peter Lenardos) and No. 3 for broking Capital Goods (Ben Thefaut, Chris Thomas, David Larkam, and Graham Webster).

Individually, Jeremy Grime and Sarah Spikes were voted the No. 1 and No. 2 analysts in Financials.

Extel 2010 is based on record participation across the professional investment community, with data and processes independently verified by Deloitte.

Commenting on the result, Jonathan Keeling, CEO of Arden said;

"We are delighted that our teams and individuals have been recognised by the buy-side community at these awards. We have a strong capability in our research department across our specialist sectors and these awards demonstrate our commitment to recruiting and retaining quality analysts and salespeople to provide leading insightful analysis."

For further information, please contact:

 

Arden Partners plc 020 7614 5900

Jonathan Keeling - Chief Executive Officer

 

Buchanan Communications 020 7466 5000

Mark Edwards / Nicola Cronk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGUBGQUPUURQ
Date   Source Headline
4th Apr 201111:50 amRNSForm 8.5 (EPT/NON-RI)
1st Apr 201111:50 amRNSForm 8.5 (EPT/NON-RI)
31st Mar 20113:44 pmRNSDirector/PDMR Shareholding
31st Mar 20113:35 pmRNSTotal Voting Rights
31st Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
30th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
29th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
28th Mar 20113:22 pmRNSAdditional Listing
28th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
25th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
25th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
24th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
24th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
23rd Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
22nd Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
21st Mar 20114:55 pmRNSHolding(s) in Company
21st Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
18th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
18th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
17th Mar 201111:55 amRNSForm 8.5 (EPT/NON-RI)
17th Mar 201111:54 amRNSForm 8.5 (EPT/NON-RI)
16th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
16th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
16th Mar 201110:44 amRNSAdditional Listing
15th Mar 201111:58 amRNSForm 8.5 (EPT/NON-RI)
15th Mar 201111:57 amRNSForm 8.5 (EPT/NON-RI)
11th Mar 201112:00 pmRNSAnnual Report and Accounts
11th Mar 201111:45 amRNSForm 8.5 (EPT/NON-RI)
7th Mar 201111:45 amRNSForm 8.5 (EPT/NON-RI)
4th Mar 201111:45 amRNSForm 8.5 (EPT/NON-RI)
3rd Mar 201111:45 amRNSForm 8.5 (EPT/NON-RI)
2nd Mar 201111:45 amRNSForm 8.5 (EPT/NON-RI)
1st Mar 201111:45 amRNSForm 8.5 (EPT/NON-RI)
28th Feb 201111:45 amRNSForm 8.5 (EPT/NON-RI)
25th Feb 201111:45 amRNSForm 8.5 (EPT/NON-RI)
24th Feb 201111:45 amRNSForm 8.5 (EPT/NON-RI)
23rd Feb 201111:45 amRNSForm 8.5 (EPT/NON-RI)
22nd Feb 20115:07 pmRNSHolding(s) in Company
22nd Feb 201111:45 amRNSForm 8.5 (EPT/NON-RI)
18th Feb 201111:45 amRNSForm 8.5 (EPT/NON-RI)
17th Feb 20114:58 pmRNSTransaction in own shares and Total Voting Rights
17th Feb 201111:45 amRNSForm 8.5 (EPT/NON-RI)
16th Feb 201111:50 amRNSForm 8.5 (EPT/NON-RI)
15th Feb 201112:37 pmRNSForm 8.5 (EPT/NON-RI)
15th Feb 201112:37 pmRNSForm 8.5 (EPT/NON-RI) (Amendment)
15th Feb 201112:35 pmRNSForm 8.5 (EPT/NON-RI) (Amendment)
14th Feb 201110:05 amRNSForm 8.5 (EPT/NON-RI)
14th Feb 20119:53 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 20119:40 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 20119:33 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.